Dear Diabetes Professional,
We are pleased to invite you to join us this fall for the 13th Annual Diabetes Technology Meeting, from October 31 to November 2, 2013, at the Hyatt Regency San Francisco Airport in Burlingame, California.
This will be an excellent opportunity to meet leading scientists in the field of diabetes research and learn about the latest technological advances for people with diabetes. Last year’s meeting in Bethesda, Maryland, brought together over 450 clinicians and scientists from 24 countries to focus on applying science and technology to fight diabetes.
The meeting’s goal is to assemble technology developers and users to facilitate creation of new and cost-effective tools—including an artificial pancreas—to help people with diabetes. The meeting will particularly emphasize original data. Scientists and clinicians will have plenty of opportunities to share ideas in both formal and informal settings, and gain insight into how to help decrease the physical and psychological burden of diabetes.
The format will include state-of-the-art lectures, oral presentations of abstracts, panel discussions with Q & A sessions, and two poster sessions. A syllabus of the submitted abstracts will be distributed to all attendees. Last year we received over 160 abstracts. We will be accepting abstracts on meeting topics until July 1, 2013.
On Thursday, October 31, there will be 4 optional pre-meeting workshops.
Concurrent morning workshops are:
Workshop A: Establishing and Maintaining High Standards for Blood Glucose Monitoring
Workshop B: Using Self-Monitoring Blood Glucose and Continuous Glucose Monitoring to Improve Outcomes
Concurrent afternoon sessions are:
Workshop C: Generic Blood Glucose Monitors and Generic Strips
Workshop D: Managing Patients Using New Pump and Insulin Delivery Technologies
Mid-morning and mid-afternoon snacks will be provided for workshop participants.
This year’s Diabetes Technology Meeting will include sessions on (1) mHealth, (2) Using Continuous Glucose Monitoring to Assess Metabolic Flexibility, Glucose Complexity and Glycemic Variability (3) Artificial Pancreas: Technology, (4) Artificial Pancreas: Outcomes, (5) New Insulin and Delivery Systems, (6) Tissue Reactions to Implanted CGM Sensors, (7) Novel Hypoglycemia Alarms, and (8) Future Directions in Diabetes Apps, as well as live demonstrations. As an added feature, the presentations will also incorporate an audience response system.
On each afternoon of October 31–November 1, we will have a poster session from 4:00 pm to 6:30 pm. During the conference proper, November 1–2, lunch will be provided, as well as morning and afternoon snacks.
On the evening of October 31, 2013 and November 1, 2013 we plan to offer company-sponsored sessions.
Every attendee will receive a 1-year subscription to Journal of Diabetes Science and Technology. This peer-reviewed bimonthly scientific journal is indexed by the National Library of Medicine for MEDLINE/PubMed and is the world’s first purely electronic diabetes journal (www.journalofdst.org).
We look forward to seeing you in San Francisco and sharing information about projects of mutual interest.
With best wishes,
David C. Klonoff, M.D., F.A.C.P., Fellow AIMBE
Chair, Diabetes Technology Meeting
Diabetes Technology Society